List view / Grid view

Murat Tunaboylu (Co-founder of Antiverse)

 

article

Next-generation drug design: how generative AI can tackle undruggable targets

Generative AI is broadening the boundaries of what is possible…

3 June 2025 | By

Generative AI is broadening the boundaries of what is possible in drug discovery. In this article, Murat Tunaboylu, CEO and Co-founder of Antiverse, reveals how the zeitgeist technology is enabling scientists to tackle previously undruggable targets like GPCRs and ion channels to deliver patient impact faster.